| Ki | 
                    - | 
                
                
                    | EC50 | 
                     | 
                
                
                    | IC50 | 
                    4.7±0.22 μM(RatAChE),  12.1±0.27 μM(RatBChE),  6.80±0.31 μM(HuAChE),  16.1±0.52 μM(HuBChE) | 
                
                
                    | Inhibition | 
                    77.9±0.72%(self-induced Aβ1-42 aggregation),  73.6±0.87%(HuAChE-induced Aβ1-42 aggregation),  78.9±0.64%(Cu2+-induced Aβ1-42 aggregation) | 
                
                
                    | Toxicity | 
                     | 
                
                
                    | ROS(reactive oxygen species) | 
                     | 
                
                
                    | Metal Chelating | 
                    Cu2+ | 
                
                
                    | BBB(blood-brain barrier) | 
                    PASS | 
                
                
                    | Target Protein | 
                    Butyrylcholinesterase (BChE) | 
                
                
                    | Effects | 
                    Show significant antioxidant activity and is a reversible and potent huAChE and huBChE inhibitor,  remarkably inhibit self- and Cu2+-mediated Aβ1-42 aggregation,  show good BBB penetration | 
                
                
                    | Research Models | 
                    Molecular docking,  in PC12 cell,  in Kunming mice,  in vitro | 
                
                
                    | Ref. Link | 
                     |